Cargando…

Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways

BACKGROUND: Tong-Xie-Yao-Fang (TXYF) has been shown to be effective in diarrhoea-predominant irritable bowel syndrome (IBS-D) patients. However, the underlying mechanism remains to be clarified. The aim of this study was to investigate the efficacy and related mechanisms of TXYF in an IBS-D rat mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Qiuke, Huang, Yongquan, Zhu, Zhaoyang, Liao, Liu, Chen, Xinlin, Han, Quanbin, Liu, Fengbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882330/ https://www.ncbi.nlm.nih.gov/pubmed/31775739 http://dx.doi.org/10.1186/s12906-019-2749-4

Ejemplares similares

Effect of TongXie-YaoFang on Cl(−) and HCO(3) (−) Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats
por: Lu, Xiaofang, et al.
Publicado: (2016)

Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats
por: Zhao, Xue-Ying, et al.
Publicado: (2019)

Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation
por: Li, Junchen, et al.
Publicado: (2018)

The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats
por: Ma, Xiangxue, et al.
Publicado: (2017)

Mechanism of the Treatment of Irritable Bowel Syndrome with Sini Powder and Tong Xie Yao Fang Decoction Based on Network Pharmacology
por: Tang, Rong, et al.
Publicado: (2022)

Modified Tong Xie Yao Fang relieves solitary rectal ulcer syndrome: A case report
por: Zhang, Li-Li, et al.
Publicado: (2019)

Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis
por: Chen, Kai, et al.
Publicado: (2021)

Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl(-) and HCO(3)(-) channel
por: Yang, Cheng, et al.
Publicado: (2016)

Effectiveness of Tong-Xie-Yao-Fang combined with Si-Ni-San for irritable bowel syndrome: A protocol for systematic review and meta-analysis
por: Jiang, Jiawang, et al.
Publicado: (2021)

Mechanism by Which Tong Xie Yao Fang Heals the Intestinal Mucosa of Rats with Ulcerative Colitis through the Hippo Pathway
por: You, Wenli, et al.
Publicado: (2021)

Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial
por: Wang, Yan, et al.
Publicado: (2020)

Exploring the Molecular Mechanism of Tong Xie Yao Fang in Treating Ulcerative Colitis Using Network Pharmacology and Molecular Docking
por: Zou, Menglong, et al.
Publicado: (2022)

Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis
por: Gong, Shan-Shan, et al.
Publicado: (2018)

Efficacy of Compound Herbal Medicine Tong-Xie-Yao-Fang for Acute Radiation Enteritis and Its Potential Mechanisms: Evidence from Transcriptome Analysis
por: Yang, Cheng, et al.
Publicado: (2020)

Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction
por: Zhang, Changrong, et al.
Publicado: (2020)

MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats
por: Hou, Qiuke, et al.
Publicado: (2018)

Lactobacillus casei LC01 Regulates Intestinal Epithelial Permeability through miR-144 Targeting of OCLN and ZO1
por: Hou, Qiuke, et al.
Publicado: (2020)

Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial
por: Wang, Xiao-xiang, et al.
Publicado: (2014)

Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology
por: Tan, Xiang, et al.
Publicado: (2020)

Xuan Bi Tong Yu Fang Promotes Angiogenesis via VEGF-Notch1/Dll4 Pathway in Myocardial Ischemic Rats
por: Li, Shuangdi, et al.
Publicado: (2020)

Tang-Tong-Fang Confers Protection against Experimental Diabetic Peripheral Neuropathy by Reducing Inflammation
por: Li, Mingdi, et al.
Publicado: (2015)

Mechanism of QingHuaZhiXie Prescription Regulating TLR4-IECs Pathway in the Intervention of Diarrhea Predominant Irritable Bowel Syndrome
por: Huang, Hua, et al.
Publicado: (2021)

Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
por: Zhu, Lingping, et al.
Publicado: (2018)

Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome
por: Lacy, Brian E.
Publicado: (2018)

Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome
por: Sun, Jing, et al.
Publicado: (2023)

Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome
por: Yang, Jingze, et al.
Publicado: (2021)

Metabolomics-Based Pharmacodynamic Analysis of Zhuang Yao Shuang Lu Tong Nao Granules in a Rat Model of Ischemic Cerebral Infarction
por: Zhai, Yang, et al.
Publicado: (2022)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019)

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
por: Prospero, Laura, et al.
Publicado: (2021)

Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome
por: Ma, Yu-xia, et al.
Publicado: (2013)

Randomised clinical trial: exploratory phase 2 study of ONO‐2952 in diarrhoea‐predominant irritable bowel syndrome
por: Whitehead, W. E., et al.
Publicado: (2016)

Quantifying Liver Stagnation Spleen Deficiency Pattern for Diarrhea Predominate Irritable Bowel Syndromes Using Multidimensional Analysis Methods
por: Huang, Zhongyu, et al.
Publicado: (2018)

San Jie Tong Mai Fang Protects Against Atherosclerosis Progression by Regulating Macroautophagy through the PI3K/AKT/mTOR Signaling Pathway
por: Li, Pengfei, et al.
Publicado: (2023)

FuZhengHuaYuJiangZhuTongLuoFang Prescription Modulates Gut Microbiota and Gut-Derived Metabolites in UUO Rats
por: Chen, Ziwei, et al.
Publicado: (2022)

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
por: Fodor, Anthony A., et al.
Publicado: (2018)

Effects of herb-partitioned moxibustion for diarrhoea-predominant irritable bowel syndrome: A protocol for systematic review and meta-analysis
por: Wang, Fen, et al.
Publicado: (2020)

Pharmacological Effects of the Water Fraction of Key Components in the Traditional Chinese Prescription Mai Tong Fang on 3T3-L1 Adipocytes and ob/ob Diabetic Mice
por: Ma, Liang, et al.
Publicado: (2014)

Mucosal Mast Cell Count Is Associated With Intestinal Permeability in Patients With Diarrhea Predominant Irritable Bowel Syndrome
por: Lee, Hyuk, et al.
Publicado: (2013)

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
por: Krogius-Kurikka, Lotta, et al.
Publicado: (2009)

Psoralen accelerates osteogenic differentiation of human bone marrow mesenchymal stem cells by activating the TGF-β/Smad3 pathway
por: Huang, Yongquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67r1qach4ikju1rrrev0i27d8u